Literature DB >> 15492480

Role of aberrant iron homeostasis in the upregulation of transforming growth factor-beta1 in the kidney of angiotensin II-induced hypertensive rats.

Kan Saito1, Nobukazu Ishizaka, Toru Aizawa, Masataka Sata, Naoyuki Iso-O, Eisei Noiri, Minoru Ohno, Ryozo Nagai.   

Abstract

We have previously shown that abnormal iron metabolism might be one underlying mechanism of the renal damage observed in the angiotensin II-infused rat. Transforming growth factor-beta1 (TGF-beta1) is known to play a crucial role in the development of renal damage induced by activation of the renin-angiotensin-aldosterone system. The purpose of the present study was to examine the effects of an iron chelator and a free radical scavenger on the angiotensin II-induced upregulation of TGF-beta1 in the kidney. Rats were given angiotensin II (0.7 mg/kg/day) via osmotic minipumps for 7 days. The expressions of the mRNAs of TGF-beta1 and collagen types I and IV were significantly increased in response to angiotensin II treatment. Histologic analysis showed that TGF-beta1 expression was upregulated mainly in tubular epithelial cells, and occasionally in glomerular and perivascular cells, some of which were identified as monocytes and/or macrophages. Although tubular cells that overexpressed TGF-beta1 did not contain iron particles, angiotensin II-induced TGF-beta1 upregulation was suppressed by the iron chelator and the free radical scavenger. The free radical scavenger also suppressed angiotensin II-induced upregulation of heme oxygenase-1, an oxidative-stress sensitive gene. By contrast, administration of iron dextran to rats induced upregulation of TGF-beta1 mRNA. Collectively, these data suggest that the renal iron overload and presumed subsequent increase in oxidative stress play a role in angiotensin II-induced upregulation of the mRNAs of TGF-beta1 and collagen types I and IV in the kidney.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15492480     DOI: 10.1291/hypres.27.599

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  7 in total

1.  Molecular and Cellular Effect of Angiotensin 1-7 on Hypertensive Kidney Disease.

Authors:  Yuanjian Chen; Wenyuan Zhao; Chang Liu; Weixin Meng; Tieqiang Zhao; Syamal K Bhattacharya; Yao Sun
Journal:  Am J Hypertens       Date:  2019-04-22       Impact factor: 2.689

2.  Ovine fetal renal development impacted by multiple fetuses and uterine space restriction.

Authors:  K M Meyer-Gesch; M Y Sun; J M Koch; J Ramadoss; S E Blohowiak; R R Magness; P J Kling
Journal:  J Dev Orig Health Dis       Date:  2013-10       Impact factor: 2.401

3.  Heme oxygenase activity as a determinant of the renal hemodynamic response to low-dose ANG II.

Authors:  Karl A Nath; Melissa C Hernandez; Anthony J Croatt; Zvonimir S Katusic; Luis A Juncos
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-08-11       Impact factor: 3.619

4.  Ovine uterine space restriction causes dysregulation of the renin-angiotensin system in fetal kidneys.

Authors:  Rachel A Kranch-Shorthouse; Adam S Bauer; Ronald R Magness; Gladys E Lopez; Jeffrey L Segar; Sharon E Blohowiak; Pamela J Kling
Journal:  Biol Reprod       Date:  2017-01-01       Impact factor: 4.285

5.  Dietary iron restriction alleviates renal tubulointerstitial injury induced by protein overload in mice.

Authors:  Yasumasa Ikeda; Yuya Horinouchi; Hirofumi Hamano; Tasuku Hirayama; Seiji Kishi; Yuki Izawa-Ishizawa; Masaki Imanishi; Yoshito Zamami; Kenshi Takechi; Licht Miyamoto; Keisuke Ishizawa; Ken-Ichi Aihara; Hideko Nagasawa; Koichiro Tsuchiya; Toshiaki Tamaki
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

6.  Iron chelation by deferoxamine prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction.

Authors:  Yasumasa Ikeda; Iori Ozono; Soichiro Tajima; Mizuki Imao; Yuya Horinouchi; Yuki Izawa-Ishizawa; Yoshitaka Kihira; Licht Miyamoto; Keisuke Ishizawa; Koichiro Tsuchiya; Toshiaki Tamaki
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

7.  Iron chelation suppresses secondary bleeding after intracerebral hemorrhage in angiotensin II-infused mice.

Authors:  Jie Wang; Xiao-Qin Tang; Min Xia; Cheng-Cheng Li; Chao Guo; Hong-Fei Ge; Yi Yin; Bo Wang; Wei-Xiang Chen; Hua Feng
Journal:  CNS Neurosci Ther       Date:  2021-08-04       Impact factor: 5.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.